These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 24620633
1. A case of irreversible leukoencephalopathy in a patient with C virus hepatitis treated with pegylated interferon-alpha-2b and ribavirin. Iacob SA, Petrescu AM, Iacob DG. Rom J Intern Med; 2013; 51(3-4):197-200. PubMed ID: 24620633 [Abstract] [Full Text] [Related]
2. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with Peg interferon alfa-2a and ribavirin. Ennaifer R, Cheikh M, Romdhane H, Hefaiedh R, Ben Nejma H, Bel Hadj N. Tunis Med; 2014 Jan; 92(1):42-3. PubMed ID: 24879173 [No Abstract] [Full Text] [Related]
3. Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts. Tseng PL, Chen TC, Chien YS, Hung CH, Yen YH, Chang KC, Tsai MC, Lin MT, Lee CT, Shen CH, Hu TH. Am J Kidney Dis; 2013 Oct; 62(4):789-95. PubMed ID: 23746377 [Abstract] [Full Text] [Related]
5. Taste disturbances during therapy with pegylated interferon-alpha 2b and ribavirin in patients with chronic hepatitis C. Klimacka-Nawrot E, Musialik J, Suchecka W, Petelenz M, Hartman M, Lichtański P, Błońska-Fajfrowska B. Wiad Lek; 2010 Oct; 63(4):289-99. PubMed ID: 21608370 [Abstract] [Full Text] [Related]
7. Alopecia universalis as a side effect of pegylated interferon α-ribavirin combination therapy for hepatitis C: a rare case report. Verma P, Dayal S, Jain VK, Amrani A. J Chemother; 2017 Dec; 29(6):380-382. PubMed ID: 27741937 [Abstract] [Full Text] [Related]
8. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient. Such Díaz A, Barrueco N, Esteban Alba C, Escobar Rodríguez I. Farm Hosp; 2011 Dec; 35(2):93-4. PubMed ID: 20615736 [No Abstract] [Full Text] [Related]
12. [Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection]. Hunyady B, Kovács B, Battyáni Z. Orv Hetil; 2011 Dec 11; 152(50):1997-2009. PubMed ID: 22112373 [Abstract] [Full Text] [Related]
14. [Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C]. Castellanos González M, Pérez Carreras M, Muñoz Gómez R, Castellano Tortajada G. Gastroenterol Hepatol; 2011 Oct 19; 34(8):584-5. PubMed ID: 21641684 [No Abstract] [Full Text] [Related]
16. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C]. Burgueño-Montañés C, Pérez-Álvarez R. Arch Soc Esp Oftalmol; 2011 Jun 19; 86(6):193-5. PubMed ID: 21767697 [Abstract] [Full Text] [Related]
17. A chronic subdural hematoma in a patient receiving combination therapy with pegylated interferon alfa-2b and ribavirin for chronic hepatitis C. Goto T, Ohshima S, Miura K, Shibuya T, Sato W, Dohmen T, Kamada K, Kanata R, Sakai T, Chiba M, Sugimoto Y, Minami S, Ohnishi H. Intern Med; 2013 Jun 19; 52(18):2057-60. PubMed ID: 24042512 [Abstract] [Full Text] [Related]
18. Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy. Jain S, Midha V, Sood A. Indian J Gastroenterol; 2011 Sep 19; 30(5):239-40. PubMed ID: 21986854 [No Abstract] [Full Text] [Related]
19. [Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy]. Kupś-Rzepecka J, Woźniakowska-Gesicka T, Gołabek V. Przegl Lek; 2011 Sep 19; 68(6):311-5. PubMed ID: 22039668 [Abstract] [Full Text] [Related]